New Medical Cannabis Research May Help Fight America’s Opioid Epidemic

October 31, 2018
Press Release

Washington, D.C. — Today, Congressman Matt Gaetz (R-FL) applauded the Columbia University and Columbia Care LLC for receiving a grant, through the National Institute on Drug Abuse, to study medical cannabis, chronic pain, and opioid abuse. In response to the announcement of the grant, Rep. Gaetz issued the following statement:

“My sincerest congratulations to Columbia University and Columbia Care LLC on being awarded an R21 research grant through the National Institute on Drug Abuse (NIDA). Their research will explore the potential of medical cannabis to treat pain conditions, as well as how cannabis may lessen opioid abuse and overdose risks. This forward-looking research will prove valuable in fighting America’s opioid epidemic. Medical cannabis has already shown tremendous potential to mitigate chronic pain, without the health and addiction risks posed by opioids, which have brought tragedy and heartbreak to far too many American families. Research such as this makes it even clearer that Congress must act now to change America’s outdated cannabis laws. Medical marijuana is real medicine, with real potential to treat some of America’s most epidemic health conditions. I will continue pushing in Congress to reform our cannabis laws, and I am eager to see the results of Columbia University and Columbia Care’s research,” Rep. Gaetz said.